The Most Notable FDA Approvals in 2022
Here is a brief recap of some of the most notable advances and the U.S. Food and Drug Administration (FDA) approvals in 2022.
Here is a brief recap of some of the most notable advances and the U.S. Food and Drug Administration (FDA) approvals in 2022.
It is widely accepted and recognized that psychodermatologic issues are commonly encountered in dermatological practices.
The U.S. Food and Drug Administration (FDA) has approved the
Alopecia is the abnormal loss of hair on the scalp,
In the past decade, awareness has been raised around improving
The COVID-19 pandemic has challenged health care, and particularly the
The American Academy of Dermatology’s last guidelines to aid clinicians
Interest in Janus kinase (JAK) inhibitors, targeted systemic treatments used
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2023, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.